These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control study. Khatami A; Damber JE; Lodding P; Pihl CG; Hugosson J Scand J Urol Nephrol; 2003; 37(3):213-7. PubMed ID: 12775279 [TBL] [Abstract][Full Text] [Related]
3. [Radical prostatectomy reduces the risk of death in prostatic cancer. The effect on total mortality can not be established yet as shown in a randomized controlled trial]. Bill-Axelson A; Holmberg L; Johansson JE; Norlén BJ Lakartidningen; 2003 May; 100(19):1714-6. PubMed ID: 12800296 [No Abstract] [Full Text] [Related]
4. Pretreatment prostate-specific antigen velocity and the risk of death from prostate cancer in the individual with low-risk prostate cancer. D'Amico AV; Chen MH J Clin Oncol; 2009 Aug; 27(22):3575-6. PubMed ID: 19506151 [No Abstract] [Full Text] [Related]
5. Obesity and prostate cancer: an insight into postmodern medicine. Siddiqui SA J Urol; 2009 Jul; 182(1):14-5. PubMed ID: 19450848 [No Abstract] [Full Text] [Related]
6. Prostate cancer screening. Witte MN; Morton RA Am Fam Physician; 1998 Aug; 58(2):342, 345-6, 348. PubMed ID: 9713390 [No Abstract] [Full Text] [Related]
7. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. van der Poel HG Eur Urol; 2009 May; 55(5):1133-4. PubMed ID: 18585847 [No Abstract] [Full Text] [Related]
8. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results. Roehl KA; Eggener SE; Loeb S; Smith ND; Antenor JA; Catalona WJ Urol Oncol; 2006; 24(6):465-71. PubMed ID: 17138126 [TBL] [Abstract][Full Text] [Related]
9. Editorial comment on: Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Berney DM Eur Urol; 2009 May; 55(5):1134. PubMed ID: 18585844 [No Abstract] [Full Text] [Related]
10. Prognostic markers under watchful waiting and radical prostatectomy. Holmberg L; Bill-Axelson A; Garmo H; Palmgren J; Norlén BJ; Adami HO; Johansson JE; Hematol Oncol Clin North Am; 2006 Aug; 20(4):845-55. PubMed ID: 16861118 [TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy. Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211 [TBL] [Abstract][Full Text] [Related]
12. Contemporary view of prostate cancer diagnosis and treatment. Costello AJ Aust Fam Physician; 2003 Jun; 32(6):396-8. PubMed ID: 12833761 [No Abstract] [Full Text] [Related]
13. Radical prostatectomy for early prostate cancer improves long term survival. Alibhai SM; Gogov S Cancer Treat Rev; 2005 Dec; 31(8):640-3. PubMed ID: 16289577 [No Abstract] [Full Text] [Related]
15. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database. King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935 [TBL] [Abstract][Full Text] [Related]
16. [Radical prostatectomy is not documented]. Gøtzsche PC Ugeskr Laeger; 1999 Oct; 161(41):5691-2. PubMed ID: 10565243 [No Abstract] [Full Text] [Related]
17. New trial data do not end the PSA screening debate. Vastag B J Natl Cancer Inst; 2009 Jun; 101(12):844-5. PubMed ID: 19509364 [No Abstract] [Full Text] [Related]
18. Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Gupta A; Lotan Y; Ashfaq R; Roehrborn CG; Raj GV; Aragaki CC; Montorsi F; Shariat SF Eur Urol; 2009 May; 55(5):1124-33. PubMed ID: 18585843 [TBL] [Abstract][Full Text] [Related]
19. Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. Schulz RJ; Kagan AR J Natl Cancer Inst; 2009 Jan; 101(2):124. PubMed ID: 19141784 [No Abstract] [Full Text] [Related]